These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31673231)

  • 1. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
    Bui HTT; Le NH; Le QA; Kim SE; Lee S; Kang D
    Int J Med Sci; 2019; 16(11):1412-1423. PubMed ID: 31673231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway.
    Zhao LM; Li L; Huang Y; Han LJ; Li D; Huo BJ; Dai SL; Xu LY; Zhan Q; Shan BE
    Mol Carcinog; 2019 Jun; 58(6):1033-1045. PubMed ID: 30737960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAPE promotes TRAIL-induced apoptosis through the upregulation of TRAIL receptors via activation of p38 and suppression of JNK in SK-Hep1 hepatocellular carcinoma cells.
    Kim EY; Ryu JH; Kim AK
    Int J Oncol; 2013 Oct; 43(4):1291-300. PubMed ID: 23857473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
    Guo X; Meng Y; Sheng X; Guan Y; Zhang F; Han Z; Kang Y; Tai G; Zhou Y; Cheng H
    Anticancer Drugs; 2017 Jan; 28(1):66-74. PubMed ID: 27603596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
    Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.
    Shlyakhtina Y; Pavet V; Gronemeyer H
    Cell Death Dis; 2017 Aug; 8(8):e3025. PubMed ID: 29048428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
    Kim SL; Min IS; Park YR; Lee ST; Kim SW
    Int J Oncol; 2018 Dec; 53(6):2789-2799. PubMed ID: 30221676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules.
    Hwang MK; Ryu BJ; Kim SH
    Amino Acids; 2012 Oct; 43(4):1679-87. PubMed ID: 22354145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
    Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
    Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MEK sensitizes gastric cancer cells to TRAIL-induced apoptosis.
    Wu P; Cheng YW; Wang JY; Zhang XD; Zhang LJ
    Neoplasma; 2014; 61(2):136-43. PubMed ID: 24299309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5.
    Kim EY; Yu JS; Yang M; Kim AK
    Mol Cells; 2013 Jan; 35(1):32-40. PubMed ID: 23224239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin.
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Med Oncol; 2015 Apr; 32(4):133. PubMed ID: 25796504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells.
    Lim SC; Duong HQ; Parajuli KR; Han SI
    Oncol Rep; 2012 Oct; 28(4):1429-34. PubMed ID: 22824956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation.
    Moon DO; Kim MO; Choi YH; Kim GY
    Mol Cancer Ther; 2010 Jun; 9(6):1583-95. PubMed ID: 20515942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of TRAIL with bortezomib shifted apoptotic signaling from DR4 to DR5 death receptor by selective internalization and degradation of DR4.
    Bychkov ML; Gasparian ME; Dolgikh DA; Kirpichnikov MP
    PLoS One; 2014; 9(10):e109756. PubMed ID: 25310712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
    Chen L; Meng Y; Guo X; Sheng X; Tai G; Zhang F; Cheng H; Zhou Y
    Apoptosis; 2016 Nov; 21(11):1291-1301. PubMed ID: 27629794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
    Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.
    Li L; Wen XZ; Bu ZD; Cheng XJ; Xing XF; Wang XH; Zhang LH; Guo T; Du H; Hu Y; Fan B; Ji JF
    Oncol Rep; 2016 May; 35(5):3009-17. PubMed ID: 26986870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells.
    Kabore AF; Sun J; Hu X; McCrea K; Johnston JB; Gibson SB
    Apoptosis; 2006 Jul; 11(7):1175-93. PubMed ID: 16699949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.